CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 2 Multi-center, Open-label, Single Arm Study of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05997056
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-08-26T00:08:28.013134+00:00
Published At: 2026-08-25T00:00:00+00:00
Record Updated At: 2026-08-25
Results Posted At: 2026-08-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neuroendocrine Tumors", "NET", "Pancreatic Neuroendocrine Tumor", "Gastrointestinal Neuroendocrine Tumor", "Pulmonary Neuroendocrine Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-08-25"
protocolSection.identificationModule.nctId: "NCT05997056"
protocolSection.identificationModule.officialTitle: "A Phase 2 Multi-center, Open-label, Single Arm Study of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-08-25"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.